Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Alice Weaver

Concepts (126)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
7
2026
563
2.210
Why?
Human papillomavirus 16
2
2024
27
1.270
Why?
Papillomavirus Infections
3
2025
345
1.120
Why?
Career Choice
3
2022
237
0.970
Why?
Carcinoma, Squamous Cell
5
2017
628
0.850
Why?
Salivary Gland Neoplasms
1
2023
39
0.740
Why?
CD8-Positive T-Lymphocytes
2
2026
931
0.680
Why?
Personnel Selection
1
2019
90
0.540
Why?
Students, Medical
2
2019
383
0.510
Why?
Fibroblast Growth Factor 1
1
2016
12
0.480
Why?
Receptor, Notch1
1
2016
62
0.470
Why?
Oropharyngeal Neoplasms
1
2016
56
0.460
Why?
Schools, Medical
1
2017
158
0.460
Why?
Mouth Neoplasms
1
2016
88
0.450
Why?
Education, Medical, Graduate
2
2022
568
0.450
Why?
Poly(ADP-ribose) Polymerases
1
2015
88
0.440
Why?
Calcium-Binding Proteins
1
2016
221
0.430
Why?
DNA Breaks, Double-Stranded
1
2015
55
0.430
Why?
Biomedical Research
2
2022
729
0.420
Why?
DNA Repair
2
2015
255
0.400
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2015
139
0.390
Why?
Robotic Surgical Procedures
1
2016
210
0.380
Why?
Communication
1
2019
980
0.370
Why?
Papillomaviridae
2
2025
113
0.330
Why?
Curriculum
1
2017
1079
0.300
Why?
Neoplasm Recurrence, Local
1
2016
1160
0.300
Why?
Internship and Residency
1
2019
1281
0.280
Why?
Prognosis
3
2026
4351
0.260
Why?
STAT3 Transcription Factor
1
2026
214
0.210
Why?
Thymus Gland
1
2025
310
0.210
Why?
Papillomavirus E7 Proteins
1
2024
11
0.210
Why?
Oncogene Proteins, Viral
1
2024
18
0.210
Why?
Organoids
1
2025
143
0.200
Why?
Gene Fusion
1
2023
31
0.190
Why?
Salivary Glands
1
2023
36
0.190
Why?
Survival Analysis
2
2016
1378
0.190
Why?
Lymphocytes, Tumor-Infiltrating
1
2024
156
0.190
Why?
Cell Culture Techniques
1
2025
371
0.190
Why?
Cancer Vaccines
1
2024
161
0.190
Why?
Intracellular Signaling Peptides and Proteins
2
2015
457
0.180
Why?
Tumor Microenvironment
1
2026
747
0.180
Why?
B7-H1 Antigen
1
2023
245
0.170
Why?
Leukocytes, Mononuclear
1
2024
585
0.170
Why?
Physicians
2
2022
955
0.160
Why?
Repressor Proteins
1
2024
430
0.160
Why?
Female
9
2026
79499
0.160
Why?
Humans
14
2026
146342
0.150
Why?
Middle Aged
5
2026
36619
0.150
Why?
Mice, Inbred NOD
2
2023
598
0.140
Why?
Melanoma
1
2025
765
0.140
Why?
Aged
3
2026
26432
0.140
Why?
Retrospective Studies
3
2026
17438
0.130
Why?
Immunotherapy
1
2023
671
0.130
Why?
Cell Line, Tumor
4
2025
3545
0.130
Why?
Treatment Outcome
2
2026
11821
0.130
Why?
Alabama
1
2017
42
0.130
Why?
T-Lymphocytes
1
2025
2012
0.130
Why?
Male
6
2026
73396
0.120
Why?
Cetuximab
1
2017
110
0.120
Why?
Pyrazines
1
2017
94
0.120
Why?
Biopsy, Needle
1
2016
183
0.120
Why?
Comet Assay
1
2015
14
0.120
Why?
Tumor Suppressor p53-Binding Protein 1
1
2015
14
0.110
Why?
Homologous Recombination
1
2015
38
0.110
Why?
Statistics, Nonparametric
1
2016
426
0.110
Why?
Chemoradiotherapy
1
2017
238
0.110
Why?
BRCA1 Protein
1
2015
84
0.110
Why?
Adult
3
2026
41087
0.110
Why?
Neoplasm Transplantation
1
2015
238
0.110
Why?
Chromosomes
1
2015
105
0.110
Why?
Mice, SCID
1
2015
360
0.110
Why?
Neoplasm Invasiveness
1
2016
504
0.110
Why?
Disease-Free Survival
1
2016
778
0.100
Why?
Universities
1
2017
451
0.100
Why?
DNA, Viral
1
2016
354
0.100
Why?
Benzimidazoles
1
2015
191
0.100
Why?
Aged, 80 and over
1
2026
8391
0.100
Why?
Analysis of Variance
1
2016
1298
0.100
Why?
Gene Expression Regulation, Neoplastic
2
2017
1432
0.100
Why?
Pyrazoles
1
2017
517
0.090
Why?
Immunohistochemistry
1
2016
1712
0.090
Why?
Signal Transduction
2
2016
5246
0.090
Why?
Logistic Models
1
2016
2126
0.080
Why?
Histones
1
2015
670
0.080
Why?
Mice
4
2025
18297
0.070
Why?
Xenograft Model Antitumor Assays
2
2025
930
0.070
Why?
Membrane Proteins
1
2014
1130
0.070
Why?
Neoplasms
1
2024
2954
0.070
Why?
Phenotype
1
2015
3206
0.060
Why?
Apoptosis
1
2015
2439
0.060
Why?
Follow-Up Studies
1
2016
5439
0.060
Why?
Risk Assessment
1
2016
3712
0.060
Why?
Cohort Studies
1
2016
6077
0.060
Why?
Cancer-Associated Fibroblasts
1
2025
23
0.060
Why?
Antineoplastic Agents
1
2017
2219
0.060
Why?
Coculture Techniques
1
2025
245
0.050
Why?
Animals
4
2025
38107
0.050
Why?
Surveys and Questionnaires
1
2017
6073
0.050
Why?
Antigens, Neoplasm
1
2025
271
0.050
Why?
Induced Pluripotent Stem Cells
1
2025
269
0.050
Why?
Programmed Cell Death 1 Receptor
1
2023
268
0.040
Why?
Flow Cytometry
1
2025
1163
0.040
Why?
Lung Neoplasms
1
2014
2675
0.040
Why?
Personal Satisfaction
1
2022
218
0.040
Why?
Minority Groups
1
2022
286
0.040
Why?
United States
1
2016
16136
0.030
Why?
Checkpoint Kinase 2
1
2017
27
0.030
Why?
Checkpoint Kinase 1
1
2017
27
0.030
Why?
Drug Synergism
1
2017
354
0.030
Why?
Myristoylated Alanine-Rich C Kinase Substrate
1
2014
6
0.030
Why?
Tissue Array Analysis
1
2014
49
0.030
Why?
Molecular Mimicry
1
2014
36
0.030
Why?
Radiation, Ionizing
1
2014
84
0.030
Why?
Radiation Tolerance
1
2014
101
0.030
Why?
DNA Damage
1
2017
439
0.030
Why?
Combined Modality Therapy
1
2017
1271
0.020
Why?
Cell Survival
1
2017
1105
0.020
Why?
Protein Structure, Tertiary
1
2014
834
0.020
Why?
Molecular Targeted Therapy
1
2014
447
0.020
Why?
Amino Acid Sequence
1
2014
2092
0.020
Why?
Peptide Fragments
1
2014
693
0.020
Why?
Molecular Sequence Data
1
2014
2838
0.020
Why?
Phosphorylation
1
2014
1724
0.020
Why?
Cell Proliferation
1
2017
2502
0.020
Why?
Adenocarcinoma
1
2014
927
0.020
Why?
Mutation
1
2014
4093
0.010
Why?
Weaver's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)